-
1
-
-
0022615261
-
Fundamental and clinical study on HBK, a new aminoglycoside in surgical field
-
T. Oka T. Tanaka Y. Omori G. Ishimine Y. Ueda M. Shimizu, et al. 1986 Fundamental and clinical study on HBK, a new aminoglycoside in surgical field Jpn J Chemother 34 Suppl1 575 582
-
(1986)
Jpn J Chemother
, vol.34
, Issue.SUPPL1
, pp. 575-582
-
-
Oka, T.1
Tanaka, T.2
Omori, Y.3
Ishimine, G.4
Ueda, Y.5
Shimizu, M.6
-
2
-
-
0023140559
-
Pharmacokinetics of habekacin in patients with renal insufficiency
-
J.P. Fillastre A. Leroy G. Humbert B. Moulin P. Bernadet S. Josse 1987 Pharmacokinetics of habekacin in patients with renal insufficiency Antimicrob Agents Chemother 31 575 577 1:CAS:528:DyaL2sXktFOitLo%3D 3606062 (Pubitemid 17054339)
-
(1987)
Antimicrobial Agents and Chemotherapy
, vol.31
, Issue.4
, pp. 575-577
-
-
Fillastre, J.P.1
Leroy, A.2
Humbert, G.3
-
4
-
-
0030734122
-
Administration of aminoglycosides to hemodialysis patients immediately before dialysis: A new dosing modality
-
1:CAS:528:DyaK2sXnvFWjsr0%3D 9420025
-
H. Matsuo J. Hayashi K. Ono K. Andoh Y. Andoh Y. Sano, et al. 1997 Administration of aminoglycosides to hemodialysis patients immediately before dialysis: a new dosing modality Antimicrob Agents Chemother 41 2597 2601 1:CAS:528:DyaK2sXnvFWjsr0%3D 9420025
-
(1997)
Antimicrob Agents Chemother
, vol.41
, pp. 2597-2601
-
-
Matsuo, H.1
Hayashi, J.2
Ono, K.3
Andoh, K.4
Andoh, Y.5
Sano, Y.6
-
7
-
-
0019854279
-
A pharmacokinetic analysis program (multi) for microcomputer
-
1:CAS:528:DyaL38XksFyntg%3D%3D 7328489
-
K. Yamaoka Y. Tanigawara T. Nakagawa T. Uno 1981 A pharmacokinetic analysis program (multi) for microcomputer J Pharmacobiodyn 4 879 885 1:CAS:528:DyaL38XksFyntg%3D%3D 7328489
-
(1981)
J Pharmacobiodyn
, vol.4
, pp. 879-885
-
-
Yamaoka, K.1
Tanigawara, Y.2
Nakagawa, T.3
Uno, T.4
-
8
-
-
0242552660
-
Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patients
-
DOI 10.1177/0091270003260286
-
C. Robatel L.A. Decosterd J. Biollaz P. Eckert M.D. Schaller T. Buclin 2003 Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patients J Clin Pharmacol 43 1329 1340 10.1177/0091270003260286 1:CAS:528:DC%2BD3sXpvFOnsLw%3D 14615469 (Pubitemid 37433306)
-
(2003)
Journal of Clinical Pharmacology
, vol.43
, Issue.12
, pp. 1329-1340
-
-
Robatel, C.1
Decosterd, L.A.2
Biollaz, J.3
Eckert, P.4
Schaller, M.D.5
Buclin, T.6
-
9
-
-
0034021031
-
Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration
-
10.1097/00003246-200003000-00005 1:STN:280:DC%2BD3c3hsVCrsg%3D%3D 10752806
-
L.J. Giles A.C. Jennings A.H. Thomson G. Creed R.J. Beale A. McLuckie 2000 Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration Crit Care Med 28 632 637 10.1097/00003246-200003000-00005 1:STN:280:DC%2BD3c3hsVCrsg%3D%3D 10752806
-
(2000)
Crit Care Med
, vol.28
, pp. 632-637
-
-
Giles, L.J.1
Jennings, A.C.2
Thomson, A.H.3
Creed, G.4
Beale, R.J.5
McLuckie, A.6
-
10
-
-
39749191259
-
Pharmacokinetic modeling and dosage adaptation of biapenem in Japanese patients during continuous venovenous hemodiafiltration
-
DOI 10.1007/s10156-007-0572-1
-
K. Ikawa N. Morikawa K. Ikeda H. Suyama 2008 Pharmacokinetic modeling and dosage adaptation of biapenem in Japanese patients during continuous venovenous hemodiafiltration J Infect Chemother 14 35 39 10.1007/s10156-007-0572-1 1:CAS:528:DC%2BD1cXitleqtrw%3D 18297447 (Pubitemid 351311438)
-
(2008)
Journal of Infection and Chemotherapy
, vol.14
, Issue.1
, pp. 35-39
-
-
Ikawa, K.1
Morikawa, N.2
Ikeda, K.3
Suyama, H.4
-
11
-
-
0023183620
-
Absorption, distribution, and excretion of arbekacin after intravenous and intramuscular administration in rats
-
1:CAS:528:DyaL2sXksFWgsbo%3D 3599384
-
N. Mitomi T. Matsumoto M. Fujigaki I. Komiya F. Kai 1987 Absorption, distribution, and excretion of arbekacin after intravenous and intramuscular administration in rats Jpn J Antibiot 40 357 364 1:CAS:528:DyaL2sXksFWgsbo%3D 3599384
-
(1987)
Jpn J Antibiot
, vol.40
, pp. 357-364
-
-
Mitomi, N.1
Matsumoto, T.2
Fujigaki, M.3
Komiya, I.4
Kai, F.5
-
12
-
-
6944222641
-
Study of clinical significance of PK/PD (pharmacokinetic/pharmacodynamic) parameters after administering arbekacin to patients with pulmonary methicillin-resistant Staphylococcus aureus infection
-
N. Tanikaze M. Komatsu K. Shimakawa I. Yamamoto 2004 Study of clinical significance of PK/PD (pharmacokinetic/pharmacodynamic) parameters after administering arbekacin to patients with pulmonary methicillin-resistant Staphylococcus aureus infection Jpn J Chemother 52 469 473
-
(2004)
Jpn J Chemother
, vol.52
, pp. 469-473
-
-
Tanikaze, N.1
Komatsu, M.2
Shimakawa, K.3
Yamamoto, I.4
-
13
-
-
59649127661
-
Prevalence of drug resistant gene and changes in susceptibility of methicillin-resistant Staphylococcus aureus strains isolated from 1990 to 2006 in Japan to antimicrobial agents
-
1:CAS:528:DC%2BD1MXhtFymt7k%3D
-
T. Mikuniya Y. Kato Y. Muto-Kobayashi Y. Sanbongi A. Shimizu T. Hiraishi, et al. 2009 Prevalence of drug resistant gene and changes in susceptibility of methicillin-resistant Staphylococcus aureus strains isolated from 1990 to 2006 in Japan to antimicrobial agents Jpn J Chemother 57 37 40 1:CAS:528: DC%2BD1MXhtFymt7k%3D
-
(2009)
Jpn J Chemother
, vol.57
, pp. 37-40
-
-
Mikuniya, T.1
Kato, Y.2
Muto-Kobayashi, Y.3
Sanbongi, Y.4
Shimizu, A.5
Hiraishi, T.6
-
14
-
-
0036225961
-
Can PK/PD be used in everyday clinical practice
-
DOI 10.1016/S0924-8579(02)00020-1, PII S0924857902000201
-
F. Scaglione 2002 Can PK/PD be used in everyday clinical practice? Int J Antimicrob Agents 19 349 353 10.1016/S0924-8579(02)00020-1 1:CAS:528: DC%2BD38XjtVeisLY%3D 11978506 (Pubitemid 34326395)
-
(2002)
International Journal of Antimicrobial Agents
, vol.19
, Issue.4
, pp. 349-353
-
-
Scaglione, F.1
|